This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Astec Co., Ltd., Astec, Inc.. Active years: 2025-2026.
Company Filing History:
Years Active: 2025-2026
Title: Innovations by Jonathan Michael MacGillivray Hall
Introduction
Jonathan Michael MacGillivray Hall is an accomplished inventor based in Adelaide, Australia. He has made significant contributions to the field of artificial intelligence and genetic testing. With a total of 2 patents, his work focuses on non-invasive methods for embryo selection and genetic analysis.
Latest Patents
One of his latest patents is titled "Method and system for performing non-invasive genetic testing using an artificial intelligence (AI) model." This innovative system utilizes AI to non-invasively estimate the presence of various aneuploidies and mosaicism in embryo images prior to implantation. The AI model is trained using a dataset of labeled images, allowing it to identify a wide range of risks associated with these genetic conditions. Another notable patent is "Method and system for selecting embryos," which describes an AI computational system that generates an embryo viability score from a single image. This system aids in selecting embryos for implantation during In-Vitro Fertilisation (IVF) procedures.
Career Highlights
Throughout his career, Jonathan has worked with notable companies such as Astec Co., Ltd. and Astec, Inc. His expertise in AI and genetic testing has positioned him as a leader in his field. His innovative approaches have the potential to revolutionize the way embryos are selected and assessed for viability.
Collaborations
Jonathan has collaborated with professionals like Donato Perugini and Michelle Perugini, contributing to advancements in his research and development efforts.
Conclusion
Jonathan Michael MacGillivray Hall is a pioneering inventor whose work in AI and genetic testing is shaping the future of reproductive technology. His patents reflect a commitment to improving embryo selection processes and enhancing the success rates of IVF procedures.